| __timestamp | Alnylam Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 1288519000 |
| Thursday, January 1, 2015 | 41097000 | 1465761000 |
| Friday, January 1, 2016 | 47159000 | 1598800000 |
| Sunday, January 1, 2017 | 89912000 | 1725300000 |
| Monday, January 1, 2018 | 74908000 | 1627800000 |
| Tuesday, January 1, 2019 | 219750000 | 1448800000 |
| Wednesday, January 1, 2020 | 492853000 | 1483300000 |
| Friday, January 1, 2021 | 844287000 | 1685500000 |
| Saturday, January 1, 2022 | 1037418000 | 1936300000 |
| Sunday, January 1, 2023 | 1828292000 | 2327500000 |
| Monday, January 1, 2024 | 2248243000 |
Unleashing insights
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Alnylam Pharmaceuticals, Inc. and United Therapeutics Corporation have been at the forefront of innovation, but who leads in revenue generation?
From 2014 to 2023, United Therapeutics consistently outpaced Alnylam in revenue, with a peak in 2023 where it generated approximately 27% more revenue than Alnylam. However, Alnylam's growth trajectory is noteworthy, with a staggering 3,500% increase in revenue from 2014 to 2023, compared to United Therapeutics' 80% growth.
As Alnylam continues to close the gap, the competition intensifies. Investors and industry watchers should keep an eye on these two giants as they navigate the challenges and opportunities in the biotech sector.
Revenue Showdown: Bristol-Myers Squibb Company vs Alnylam Pharmaceuticals, Inc.
Revenue Insights: Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Genmab A/S
Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Alnylam Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Alnylam Pharmaceuticals, Inc. and Mesoblast Limited: A Comprehensive Revenue Analysis
Annual Revenue Comparison: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Revenue Showdown: United Therapeutics Corporation vs Alkermes plc
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation or BioCryst Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
United Therapeutics Corporation and Evotec SE: A Comprehensive Revenue Analysis